在神经内分泌瘤中探索癌症综合征:来自多学科叙事审查的见解
Matteo Marasco1,2, Elena Romano1, Giulia Arrivi3
1Digestive Disease Unit, Sant' Andrea University Hospital, ENETS Center of Excellence, 00189 Rome, Italy.
Cancers
|November 27, 2024
概括
癌症综合征 (CS),与神经内分泌瘤 (NETs) 相关,需要多学科护理的症状,如发红和腹. 治疗重点是控制症状,减少瘤负担,以改善生活质量.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
背景情况:
- 癌症综合征 (CS) 是一种与神经内分泌瘤 (NETs) 相关的罕见疾病,主要是胃肠道瘤.
- CS涉及生物活性物质的分泌,特别是血清素,导致复杂的症状.
- 临床表现包括脸红,腹,支气管和癌性心脏病.
研究的目的:
- 概述癌症综合征的多学科管理方法.
- 审查目前的治疗方案,以控制症状和减少瘤负担.
- 强调管理CS并发症的重要性,以改善患者的生活质量.
主要方法:
- 审查当前文献和治疗癌症综合征的治疗指南.
- 描述各种医疗专家参与的协作,多学科方法.
- 讨论药理学,放射学和手术治疗策略.
主要成果:
- 索马托斯塔丁类型 (SSA) 是首线治疗,用于缓解CS的症状.
- 对于进展性或耐药性疾病,选择包括向疗法,PRRT,肝脏导向治疗和手术.
- 早期发现和管理营养不良和维生素缺乏等并发症至关重要.
结论:
- 最佳的CS管理需要一个协调的,多学科的方法.
- 个性化治疗计划对于解决疾病的复杂性至关重要.
- 有效的症状和并发症管理显著提高了患者的福祉和生活质量.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147


